Zosano Pharma Corporation
ZSAN
ZSAN was delisted on the 10th of June, 2022.
19 hedge funds and large institutions have $19.7M invested in Zosano Pharma Corporation in 2019 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 5 increasing their positions, 1 reducing their positions, and 10 closing their positions.
400% more repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 1
85% more capital invested
Capital invested by funds: $10.6M → $19.7M (+$9.03M)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
17% less funds holding
Funds holding: 23 → 19 (-4)
40% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 10
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$995K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$904K |
| 3 |
Morgan Stanley
New York
|
+$259K |
| 4 |
MA
MYDA Advisors
Woodmere,
New York
|
+$252K |
| 5 |
TI
Telemetry Investments
New York
|
+$83.3K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NC
Nexthera Capital
New York
|
-$1.69M |
| 2 |
HM
HealthCor Management
New York
|
-$1.21M |
| 3 |
SM
Sabby Management
Miami Beach,
Florida
|
-$355K |
| 4 |
LOAMU
Lombard Odier Asset Management (USA)
New York
|
-$76K |
| 5 |
Northern Trust
Chicago,
Illinois
|
-$40.8K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
Bank of America
Charlotte,
North Carolina
| – | +$123 | +1 | New |
|
27
Deutsche Bank
Frankfurt Am Main Ge,
Germany
| – | +$368 | +3 | New |
|
ZSAN Hedge Fund Activity: Q1 2019 in Review
19 of the 4,620 institutional investors tracked by Wall St. Rank reported a position in Zosano Pharma Corporation (ZSAN) for Q1 2019, worth a combined $19.7M — up 85% from $10.6M a quarter earlier.
Sellers outnumbered buyers: 10 funds closed out of ZSAN and 6 opened new positions — a net loss of 4 holders — while 1 trimmed existing stakes and 5 added.
The largest buyer was BlackRock, adding an estimated $995K. The largest seller was Nexthera Capital, exiting entirely with an estimated $1.69M sold.
- 19 institutional investors held Zosano Pharma Corporation (ZSAN) as of Q1 2019, down from 23 in Q4 2018.
- Funds reported $19.7M of Zosano Pharma Corporation stock for Q1 2019, up 85% quarter-over-quarter.
- 6 funds opened new Zosano Pharma Corporation positions in Q1 2019 and 10 closed out, a net change of -4 holders.
- The largest Zosano Pharma Corporation buyer in Q1 2019 was BlackRock, an estimated $995K added.
- The largest Zosano Pharma Corporation seller in Q1 2019 was Nexthera Capital, an estimated $1.69M sold.
Based on aggregated 13F filings for Q1 2019.